参考文献/References:
1. Geoffrey A et al.Immunol Rev, 1992;129:57
2. Morrison S et al. Scince, 1985;229:1202
3. Reichmann L et al. Nature, 1988;332:323
4. Mullinax RL et al. Proc Natl Acad Sci USA, 1990;187:8095
5. Nolan O et al. Int J Clin Lab Res, 1992;22(1):21
6. John E et al. J Nuci Med, 1993;34:260
7. Barry W et al. Cancer Res, 1990;50:970
8. Howard S et al. Cancer Res, 1990;50;809
9. Jain RK et al. Cancer Metastasis Rev, 1990;9:253
10. Jain RK et al. Int J Radiat Biol, 1991;60:85
11. Steven M et al. Cancer Res, 1990;50:892
12. Goldenberg DM et al. CA Cancer J Clin, 1994, 44(1):43
相似文献/References:
[1]杨卫东,汪静.肿瘤核素靶向治疗新进展[J].国际放射医学核医学杂志,2015,39(1):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]
Yang Weidong,Wang Jing.Advance progress of radionuclide target tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]
[2]查林,冯世斌,李前伟.非霍奇金淋巴瘤的CD20分子显像及靶向治疗研究进展[J].国际放射医学核医学杂志,2010,34(5):269.[doi:10.3760/cma.j.issn.1673-4114.2010.05.004]
ZHA Lin,FENG Shi-bin,LI Qian-wei.Progress of study on the molecular imaging and targeted therapy in CD20 of non Hodgkin’s lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(2):269.[doi:10.3760/cma.j.issn.1673-4114.2010.05.004]
[3]田源,张良安.放射免疫治疗中的α核素微剂量研究[J].国际放射医学核医学杂志,2006,30(1):39.
TIAN Yuan,ZHANG Liang-an.A review of microdosimetric study in alpha particle radioimmunotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(2):39.
[4]陈立波,朱瑞森.Bexxar治疗非霍奇金淋巴瘤的研究现状[J].国际放射医学核医学杂志,2005,29(2):67.
CHEN Li-bo,ZHU Rui-sen.Current status of Bexxar for treatment of non-Hodgkin’s lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(2):67.
[5]高云朝.恶性胶质瘤的放射免疫治疗[J].国际放射医学核医学杂志,2004,28(4):149.
GAO Yun-chao.Radioimmunotherapy for malignant glioma[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(2):149.
[6]张弘.用于放免治疗的核素研究进展[J].国际放射医学核医学杂志,2003,27(4):148.
ZHANG Hong.Advances in radionuclide for radioimmunotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(2):148.
[7]李敏杰.胰腺癌的放射免疫治疗进展[J].国际放射医学核医学杂志,2003,27(4):154.
LI Min-jie.Radioimmunotherapy of pancreatic cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(2):154.
[8]袁志斌.核医学影像诊断多发性骨髓瘤的临床价值[J].国际放射医学核医学杂志,2003,27(4):162.
YUAN Zhi-bin.The clinical value of radionulide scintigraphy in the assessing of multiple myeloma[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(2):162.
[9]袁志斌.ZevalinTM:一种放射免疫治疗新药[J].国际放射医学核医学杂志,2002,26(5):225.
YUAN Zhi-bin.ZevalinTM: A new radioimmunotherapy agent[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(2):225.
[10]左传涛.肺癌放射免疫显像的临床应用[J].国际放射医学核医学杂志,2000,24(4):158.
ZUO Chuan-tao.Clinical application of radioimmunoimaging in lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2000,24(2):158.
[11]唐刚华,王世真.生物素-亲合素系统在核医学中的应用[J].国际放射医学核医学杂志,1997,21(4):145.